INSIGHTS ON DRUG DEVELOPMENT

• How Peptides Became Cornerstones Of Modern Medicine

  Peptides evolved from early chemical discoveries to transformative therapies, culminating in GLP‑1 drugs that highlight their versatility, precision, and expanding role across modern medicine.

• Assessing Production And Stability Of Antibody Drug Conjugate Platforms

  ADCs with similar antibody sequences can behave differently due to linker and payload choices. Analytical tools reveal structural and stability differences critical to therapeutic performance.

• Managing Process Knowledge Throughout Drug Development And Manufacturing

  Discover how digitalizing recipe and risk management helps life sciences teams accelerate drug development, streamline technology transfers, and simplify compliance to improve data integrity.

• Using Residual DNA Quantification Data To De-Risk mAb Development

  Residual DNA quantitation offers more than impurity measurement. When used across process steps, it helps compare purification performance, identify risks early, and ensure assays remain reliable.

• mRNA Vaccines And Therapeutics: Current Trends And Perspectives

  2/25/2025

  Delve into the advancements and transformative impact of mRNA vaccine technology on modern medicine and explore how this technology is revolutionizing healthcare for the future and beyond.

• Ask Us Anything: Jillian Sheeran On Emerging Reactor Technologies

  7/23/2026

  Jillian Sheeran, Associate Director of Engineering at Snapdragon Chemistry, on how automation, feedback control, and machine learning are changing reactor design — with real-time monitoring that lets a process run continuously while the data comes to you.

• A Comparison To Traditional Clone Screening Platforms

  8/6/2026

  See how 46 CHO clones performed across automated, deep-well, and microbioreactor fed-batch cultures, using cell density, viability, and IgG concentration to evaluate clone performance.

• Non Animal Origin Squalene For High-Risk Applications

  7/21/2025

  Explore an ethical and sustainable alternative to shark-derived squalene that is backed by robust data to deliver identical performance in vaccine formulations without environmental compromise.

• Navigating Drug Design In 'Beyond The Rule Of 5' Landscape

  6/17/2026

  New drug modalities are transforming treatment but bring new challenges. See how hybrid approaches that combine biologics and chemistry are redefining the design of innovative therapies.